Lumiera Health Inc
XTSX:NHP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innovest Global Inc
OTC:IVST
|
US |
|
K
|
Kunekt Corp
OTC:KNKT
|
HK |
|
Mosa Industrial Corp
TWSE:4564
|
TW |
|
European Green Transition PLC
LSE:EGT
|
UK |
|
D
|
Darco Water Technologies Ltd
SGX:BLR
|
SG |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Lumiera Health Inc
XTSX:NHP
|
849.9k CAD |
Loading...
|
|
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
4.1T INR |
Loading...
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
28.1B CHF |
Loading...
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
19.3B USD |
Loading...
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
113.4B CNY |
Loading...
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
46.6B CNY |
Loading...
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
5.6B USD |
Loading...
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
38.1B CNY |
Loading...
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
4.1B GBP |
Loading...
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
810.5B JPY |
Loading...
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
34.7B CNY |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Lumiera Health Inc
Glance View
Lumiera Health, Inc. engages in the commercialization and development of evidence-based botanical products for the healthcare and bio-agriculture. The company is headquartered in Montreal, Quebec. The company went IPO on 2013-11-14. The firm is focused on selling natural products as well as the development and commercialization of botanical-based products for human health care. The firm also operates as product development, marketing and sales business of natural products. The Company’s products and brands include Holizen, Awaye pain relief cream and Bazzzics. The firm is also providing solutions for chronic pain and inflammation. The company is also helping people to improve health by delivering products. The Company’s subsidiary is Holizen Laboratory Inc.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 1 years, Lumiera Health Inc’s Gross Margin has decreased from 49.8% to 22.9%. During this period, it reached a low of 22.9% on Dec 30, 2022 and a high of 49.8% on Oct 30, 2021.
